兑吧(01753.HK)一季度新籤合約總額為1890萬元 去年同期為650萬元
格隆匯5月17日丨兑吧(01753.HK)公佈,集團的用户運營SaaS業務於截至2020年3月31日止三個月的新簽約(含續約)合約數量為156份(2019年同期為125份),其中50份為與銀行類客户所籤合約。截至2020年3月31日止三個月,新籤合約(含續約)總額為人民幣1890萬元(2019年同期為人民幣650萬元)。截至2020年3月31日止三個月,新籤合約(含續約)中最高的客單價為人民幣220萬元。
董事會相信,基於集團用户運營SaaS領域積累的經驗和技術優勢,對集團用户運營SaaS業務的長遠前景充滿信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.